Related Experiment Video
Updated: Nov 28, 2025

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
Published on: August 18, 2023
Solving the Problem of Insomnia in Clinical Practice
Adrienne F Willard1, Allison H Ferris2
1Drexel University College of Medicine, 2900 West Queen Lane, Philadelphia, PA 19129, USA.
Insomnia affects half of all people, with effective psychological and medication treatments available. Physicians should guide patients in choosing the best approach for managing chronic insomnia.
Area of Science:
- Sleep Medicine
- Clinical Psychology
- Pharmacology
Background:
- Insomnia is a prevalent condition impacting roughly 50% of individuals.
- Chronic insomnia presents significant short-term and long-term health risks.
- Physicians require expertise in diagnosing and managing insomnia in outpatient settings.
Purpose of the Study:
- To review current treatment modalities for insomnia.
- To emphasize the importance of a shared decision-making model in insomnia management.
- To equip healthcare providers with knowledge for effective patient guidance.
Main Methods:
- Review of psychological interventions for insomnia.
- Analysis of pharmacologic treatments for insomnia.
- Discussion of risks and benefits associated with insomnia medications.
Main Results:
- Psychological treatments are the preferred first-line approach for insomnia.
- Pharmacologic options are effective when behavioral therapies are insufficient.
- Understanding treatment options facilitates patient engagement.
Conclusions:
- Effective treatments for insomnia, including behavioral and pharmacologic options, are available.
- Shared decision-making is crucial for tailoring insomnia treatment to individual patient needs.
- Physician preparedness is key to addressing the common complaint of insomnia.
More Related Videos
Related Concept Videos
Insomnia
Multiple factors contribute...
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
CNS Depressants: Barbiturates and Benzodiazepines
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...

